GF
OPTR

Gabelli Funds’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Gabelli Funds’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-130,000
Closed -$1.64M – 1082
2013
Q3 		$1.64M Buy
+130,000
New +$1.72M 0.01% 769

Gabelli Funds's OPTR Position: Q4 2013 in Review

Gabelli Funds sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 130,000 shares — an estimated $1.64M sold.

Gabelli Funds first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $1.64M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Gabelli Funds reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Gabelli Funds sold 130,000 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $1.64M.
  • Gabelli Funds first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • Gabelli Funds's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $1.64M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Gabelli Funds's 13F filing for Q4 2013, filed 7 Feb 2014.